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We found a low prevalence (0.6%) of carbapenemase-producing Enterobacteriaceae (CPE) in fecal microbiota of companion
dogs. A single VIM-1-producing Klebsiella pneumoniae isolate belonging to sequence type (ST) 2090 was detected. blaVIM-1 was
carried on a class 1 integron and an untypeable48-kb plasmid. Emergence and spread of CPE in this group of animals may be a
threat to public health in human and veterinary medicine. This finding supports the need for active surveillance studies in com-
panion animals that live close to humans, as interspecies transmissionmay occur within the same household.
The emergence and worldwide spread of carbapenemase-pro-ducing Enterobacteriaceae (CPE) have significantly increased
in recent years, mainly in Klebsiella pneumoniae (1–3). Most car-
bapenemases are encoded on mobile genetic elements (4), which
usually contain other antimicrobial resistance genes.
CPE and other carbapenemase-producing bacteria, which
seemed limited to humans, have also been described in animals,
particularly livestock. The detection of Pseudomonas aeruginosa
with VIM-2 and Acinetobacter baumannii with OXA-23 and
OXA-58 in livestock animals from Lebanon was recently reported
(5). Several VIM-1 carbapenemase-producing Escherichia coli and
Salmonella isolates were recovered from pigs in Germany (6, 7),
Acinetobacter spp. harboring OXA-23 was isolated from cattle in
France (8), and A. baumannii and Acinetobacter lwoffii isolates
producing NDM-1 were detected in pig and chicken sources in
China (9). In addition, NDM-1-producing Salmonella enterica
subsp. enterica serovar Corvallis was reported in Germany from a
wild bird (10). Only rarely have CPE been found in pets, specifi-
cally in three studies that detected OXA-48-producing E. coli and
K. pneumoniae fromdogs inGermany (11), NDM-1-producing E.
coli from dogs and cats in the United States (12), and OXA-23-
producing Acinetobacter spp. from horses in Belgium (13).
Since there is very little information about CPE in companion
animals, we describe here a study aimed at assessing the prevalence
of CPE in rectal swab samples from companion dogs.
BetweenOctober 2014 and January 2015, 160 rectal swab sam-
ples from different dogs who attended a veterinary hospital in
Fuenlabrada (Madrid, Spain) were collected, without any inclu-
sion or exclusion criteria, by inserting a swab into the rectum
while rotating it. The swab was then transported to the laboratory
in Amies medium. At the time of swab collection, 54% of the
animals were under antibiotic treatment. The drugs used as
monotherapy were, in order of frequency, amoxicillin-clavulanic
acid (18.6%), cephalexin (15.1%), metronidazole (9.3%), marbo-
floxacin (8.1%), sulfadoxine-trimethoprim (SxT) (7%), ampicil-
lin (4.7%), amoxicillin (3.5%), cefazolin (1.2%), nitrofurantoin
(1.2%), and azithromycin (1.2%). Antibiotic combinations in-
cluded metronidazole plus cephalexin (7%), amoxicillin-clavu-
lanic acid plus marbofloxacin (5.8%), cephalexin plus marbo-
floxacin (3.5%), metronidazole plus marbofloxacin (3.5%),
metronidazole plus marbofloxacin plus cephalexin (3.5%), met-
ronidazole plus SxT (2.3%), amoxicillin-clavulanic acid plusmet-
ronidazole (1.2%), amoxicillin-clavulanic acid plus SxT (1.2%),
marbofloxacin plus azithromycin (1.2%), and ampicillin plus
marbofloxacin (1.2%).
Samples were inoculated on a selective chromogenic medium
biplate (chromIDCarba Smart, bioMérieux), which consists of an
associated medium to screen for OXA-48 on one side and other
carbapenemases on the other side. Plates were then incubated at
37°C for 24 h in aerobic atmosphere. Susceptibility testing and
identificationwere performed on every isolate with growth on this
medium by using the Wider system (Francisco Soria Melguizo).
Phenotypic carbapenemase characterization was conducted,
according to the susceptibility testing results, on isolates that
matched EUCAST screening criteria (14) by use of the combina-
tion disk test (Rosco), which includes meropenem (10 g) alone
and combined with boronic acid, cloxacillin, and dipicolinic acid.
A temocillin disk (30 g) was used as a phenotypic indicator of
OXA-48.
In addition, isolates with growth on chromIDCarba Smart but
with negative results for carbapenemase production were further
investigated for the presence of extended-spectrum -lactamases
(ESBL) and/or AmpC-type enzymes according to EUCAST guide-
lines (14). The phenotypic confirmation method used was the
combination disk test, which included a disk containing cefo-
taxime (30 g) alone and in combination with clavulanic acid,
cloxacillin, and cloxacillin-clavulanic acid (Rosco). Furthermore,
the double-disk synergy test, which included a disk containing
cefepime and another one containing clavulanic acid, was per-
formed to confirm the presence of ESBL inEnterobacteriaceaewith
inducible chromosomal AmpC.
The presence of genes encoding carbapenemases (blaOXA-48,
blaKPC, blaVIM, blaIMP, and blaNDM) (15), ESBLs (blaTEM, blaSHV,
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and blaCTX-M) (16), and plasmid-mediated AmpC (blaCMY, blaFOX,
blaMOX, blaDHA, blaEBC, and blaACC) (17)was determined by use of
PCR and DNA sequencing assays. The sequences obtained were
compared with those available in the GenBank and Lahey Clinic
(http://www.lahey.org/Studies/) public databases.
Multilocus sequence typing (MLST) was performed for all
carbapenemase-producing isolates with the Institut Pasteur
scheme (http://www.pasteur.fr/recherche/genopole/PF8/mlst
/Kpneumoniae.html).
Class 1 integron structures, the integrase gene intI1 and the
variable regions, were screened by PCR amplification and DNA
sequencing (18). Conjugation experiments were performed with
carbapenemase-producing K. pneumoniae isolates with the kana-
mycin-azide-resistant E. coli HB101 as a recipient. Putative
transconjugants were selected onMueller-Hinton agar plates con-
taining kanamycin (100 g/ml), azide (160 g/ml), and cefo-
taxime (4 g/ml). Plasmids were classified according to their in-
compatibility groups by a PCR-based replicon-typing scheme
(19). Pulsed-field gel electrophoresis (PFGE) with S1 nuclease di-
gestion of whole-genomic DNA (S1-PFGE) was used to detect
plasmids as previously described (20).
Three Enterobacteriaceae from three different dogs grew on the
selective chromogenic medium biplate: two K. pneumoniae
(named 1 and 2) and one Enterobacter cloacae. Only K. pneu-
moniae 1 produced carbapenemase, and the remaining isolates
were considered false positives on the chromID Carba Smart me-
dium. Susceptibility testing results are listed in Table 1. The com-
bination disk test showed a profile compatible with CPE in the K.
pneumoniae 1 isolate confirmed by PCR and sequencing as a me-
tallo--lactamase VIM-1, belonging to the new sequence type
(ST) 2090, not related to any ST previously described. This isolate,
also resistant to trimethoprim-sulfamethoxazole, tobramycin,
and fosfomycin, was detected in a dog from an animal shelter
receiving nomedication at the time of sampling or in the previous
month. Genes encoding ESBLs or plasmid-mediated AmpC were
not detected in this isolate.
TheblaVIM-1 genewascarriedonaclass1 integron in the following
cassette combination: intI1 (integrase gene)-blaVIM-1-aac(6=)-Ib (to-
bramycin resistancegene, also calledaacA4)-dfrB1 (trimethoprimre-
sistance gene)-aadA1 (streptomycin resistance gene)-catB2 (chlor-
amphenicol resistance gene)-qacE1/sul1 (quaternary ammonium
compounds resistance gene/sulfonamide resistance gene). Carbap-
enem-nonsusceptible E. coli transconjugant was obtained from
VIM-1-producing K. pneumoniae isolates. Both the isolate from
surveillance and the transconjugant carried a plasmid of 48 kb
that was untypeable by PCR. In addition, the transconjugant was
positive for class 1 integron and blaVIM. VIM-1-producing E. coli
transconjugant also presented reduced susceptibility to tobramy-
cin and trimethoprim-sulfamethoxazole but not to fosfomycin.
TheK. pneumoniae 2 strainwas further investigated, as because
the results showed that it seemed to harbor an ESBL and a plas-
midic AmpC enzyme, confirmed as CTX-M-15 andDHA, respec-
tively. It belonged to a dog that was being treated with marbo-
floxacin and amoxicillin-clavulanate.
The double-disk synergy test with cefepime and amoxicillin-
clavulanic acid was positive for the E. cloacae strain, suggesting the
ESBL production confirmed as SHV-12 by sequencing. No genes
encoding carbapenemases were detected by PCR. The dog was
receiving cephalexin and metronidazole at the time of sampling.
The isolation of multidrug-resistant Enterobacteriaceae in
companion animals is an emerging phenomenon. Few studies de-
scribe colonization or infection of companion animals with these
organisms, but the number seems to be increasing. According to a
recent review (21), and similar to humans (22), CTX-M-type
ESBLs are themost prevalent, particularly CTX-M-1, -14, and -15,
although SHV-12 and TEM-52 have also been described, mostly
in E. coli and K. pneumoniae strains from cats and dogs; CMY-2
andDHA are themost commonAmpC-lactamases described so
far (21). Fortunately, carbapenemases are exceptionally rare in
companion animals (11–13). In veterinary medicine, -lactam
antibiotics are themost widely used antibiotics for bacterial infec-
tions (21). In dogs, first-generation cephalosporins and amoxicil-
lin-clavulanic acid are among the most commonly prescribed
(23). Nevertheless, the use of carbapenems is not currently li-
censed, although it has been reported (24). Therefore, resistance
to carbapenems is not routinely evaluated in animal isolates, so it
seems likely that its prevalence is underestimated (11).
However, although the use of carbapenems is not common
practice, the presence of genes encoding carbapenemases in mo-
bile genetic elements that can also include other antibiotic resis-
tance genes means that the use of other antimicrobials may con-
tribute to coselection (6). The detection of genes conferring
resistance to aminoglycosides, trimethoprim, and sulfonamides in
the same class 1 integron with blaVIM-1 can facilitate that coselec-
tion phenomenon.
The great increase and spread of CPE from human sources and
its recent isolation from animalsmay reflect an emerging problem
in human and veterinary medicine, as interspecies transmission
may occur between humans and companion animals within the
same household (25). Our results support this hypothesis, as the
class 1 integron and plasmid carrying blaVIM-1 detected in this
study are among the most frequent mobile genetic elements asso-
ciated with blaVIM-1 dissemination in humans (26).
In Spain, the isolation of CPE in humans has significantly in-
creased in recent years. According to a multicenter Spanish study,
including 83 hospitals, OXA-48 carbapenemase is currently the
most prevalent in Spain, followed by VIM-1, which appears much
less frequently (27). The estimated overall prevalence of infection
by carbapenemase-producingK. pneumoniaewas 1.7% (range per
hospital, 0% to 11.6%), and 23 (30.7%) hospitals had a prevalence
TABLE 1MICs of -lactam antibiotics
Antibiotic
MIC (mg/liter) for:
K. pneumoniae 1 K. pneumoniae 2 E. cloacae
Amoxicillin 16 16 16
Amoxicillin-clavulanic acid 16/8 16/8 16/8
Piperacillin-tazobactam 64/4 64/4 64/4
Cefuroxime 16 16 16
Cefoxitin 16 16 16
Ceftazidime 16 16 16
Ceftazidime-clavulanic acid 8/4 8/4 8/4
Cefotaxime 8 8 8
Cefotaxime-clavulanic acid 8/4 8/4 8/4
Cefepime 8 8 8
Aztreonam 1 8 8
Imipenem 4 1 1
Meropenem 4 2 2
Ertapenem 2 2 2
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of 1% (27). In the present study, we found a 0.6% CPE preva-
lence in companion dogs.
Emergence and spread of CPE in companion animalsmay rep-
resent an underestimated threat to public health. Our findings
support probable human-to-animal transference of carbapen-
emases genes and reveal the need for active surveillance studies in
companion animals.
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